Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org)

Diseases of the Esophagus

Volumn 23, Issue 8, 2010, Pages 646-651

  Tanaka, T ^a   Fujita, H ^a   Matono, S ^a   Nagano, T ^a   Nishimura, K ^a   Murata, K ^a   Shirouzu, K ^a   Suzuki, G ^a   Hayabuchi, N ^a   Yamana, H ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Multimodality therapy; Organ metastasis; Squamous cell cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78649517442     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01069.x     Document Type: Article

References (26)

1. Mariette C, Guillaume P, Triboulet J P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545-53.
2. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
3. Sobin L H, Wittekind C, (eds). TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002.
4. Homs M Y V, Kuipers E J, Siersema P. Palliative therapy. J Surg Oncol 2005; 92: 246-56.
5. Lightdale C J. Esophageal cancer. Am J Gastroenterol 1999; 94: 20-9.
6. Homs M Y V, Steyerberg E W, Eijkenboom W M H et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomized trial. Lancet 2004; 364: 1497-504.
7. Luketich J D, Christie N A, Buenaventura P O, Weigel T L, Keenan R J, Nguyen N T. Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period. Surg Endosc 2000; 14: 653-7.
8. Maier A, Tomaselli F, Gebhard F, Rehak P, Smolle J, Smolle-Jüttner F M. Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation. Ann Thorac Surg 2000; 69: 1006-9.
9. Herskovic A, Marz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
10. Bedenne L, Michel P, Bouché O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD9102. J Clin Oncol 2007; 25: 1160-8.
11. Gebski V, Burmeister B, Smithers B M et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.
12. Yoshizumi Y, Morisaki Y, Koike H et al. Successful combined resection of carcinoma of the esophagus and adrenal metastasis: report of a case. Surg Today 1997; 27: 330-3.
13. Yamamoto T, Tachibana M, Kinugasa S, Yoshimura H, Nagasue N. Esophagectomy and hepatic arterial chemotherapy following hepatic resection for esophageal cancer with liver metastasis. J Gastroenterol 2001; 36: 560-3.
14. Kosugi S I, Kanda T, Nishimaki T et al. Successful treatment for esophageal carcinoma with lung metastasis by induction chemotherapy followed by salvage esophagectomy: report of a case. World J Gastroenterol 2006; 12: 4101-3.
15. Iwase H, Shimada M, Nakamura M et al. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: long-term results of a phase II study of UFT/CDDP with radiotherapy. Int J Clin Oncol 2003; 8: 305-11.
16. Iizuka T, Kakegawa T, Ide H et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese esophageal oncology group trial. Jpn J Clin Oncol 1992; 22: 172-6.
17. Hayashi K, Ando N, Watanabe H et al. Phase II evaluation of protracted infusion of cisplatin and 5-fluouracil in advanced squamous cell carcinoma of the esophagus: a Japan esophageal oncology group (JEOG) trial (JCOG9407). Jpn J Clin Oncol 2001; 31: 419-23.
18. Bleiberg H, Conroy T, Paillot B et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997; 33: 1216-20.
19. Polee M B, Eskens F A L M, Van Der Burg M E L et al. Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. Br J Cancer 2002; 86: 669-73.
20. 0 squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003; 57: 425-33.
21. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
22. Fujita H, Sueyoshi S, Tanaka T et al. Esophagectomy: is it necessary after chemoradiotherapy for locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005; 29: 25-31.
23. Penniment M. A randomized phase III study in advanced oesophageal cancer to compare quality of life and palliation of dysphagia in patients treated with radiotherapy vs chemoradiotherapy (TROG 03.01/NCIC CTG ES2). 2003. [Cited 20 Mar 2010.] Available from URL: .
24. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the esophagus. Ann Surg 1994; 220: 364-72.
25. Fujita H, Kakegawa T, Yamana H et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222: 654-62.
26. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232: 225-32.